Trials / Not Yet Recruiting
Not Yet RecruitingNCT06888479
Optimal Timing of Hepatitis B Vaccination After Transplants
Optimal Timing of Hepatitis B Vaccination After Transplants: a Randomized Clinical Study
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,500 (estimated)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aim to perform a randomized clinical trial to determine the optimal timing of hepatitis B vaccination after hematopoietic cell transplantation (HCT) through evaluating the immunity effect of two different vaccination schedules (initiated at 3 or 6 months after transplantation) in patients with different immune reconstitution status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | hepatitis B vaccine | Three doses of hepatitis B vaccine |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2028-06-01
- Completion
- 2029-03-01
- First posted
- 2025-03-21
- Last updated
- 2025-03-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06888479. Inclusion in this directory is not an endorsement.